109 related articles for article (PubMed ID: 19845529)
1. E1AF expression is associated with extra-prostatic growth and matrix metalloproteinase-7 expression in prostate cancer.
Maruta S; Sakai H; Kanda S; Hayashi T; Kanetake H; Miyata Y
APMIS; 2009 Nov; 117(11):791-6. PubMed ID: 19845529
[TBL] [Abstract][Full Text] [Related]
2. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract][Full Text] [Related]
3. Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
Yamamoto H; Horiuchi S; Adachi Y; Taniguchi H; Nosho K; Min Y; Imai K
Carcinogenesis; 2004 Mar; 25(3):325-32. PubMed ID: 14604892
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes.
Hanzawa M; Shindoh M; Higashino F; Yasuda M; Inoue N; Hida K; Ono M; Kohgo T; Nakamura M; Notani K; Fukuda H; Totsuka Y; Yoshida K; Fujinaga K
Carcinogenesis; 2000 Jun; 21(6):1079-85. PubMed ID: 10836994
[TBL] [Abstract][Full Text] [Related]
5. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
Cardillo MR; Di Silverio F; Gentile V
Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
[TBL] [Abstract][Full Text] [Related]
6. Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis.
Nosho K; Yoshida M; Yamamoto H; Taniguchi H; Adachi Y; Mikami M; Hinoda Y; Imai K
Carcinogenesis; 2005 May; 26(5):892-9. PubMed ID: 15695237
[TBL] [Abstract][Full Text] [Related]
7. Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.
Hata H; Kitamura T; Higashino F; Hida K; Yoshida K; Ohiro Y; Totsuka Y; Kitagawa Y; Shindoh M
Oncol Rep; 2008 May; 19(5):1093-8. PubMed ID: 18425363
[TBL] [Abstract][Full Text] [Related]
8. E1AF expression is closely correlated with malignant phenotype of tongue squamous cell carcinoma through activation of MT1-MMP gene promoters.
Izumiyama Y; Ohiro Y; Higashino F; Yoshida K; Taguchi K; Todo S; Kohgo T; Totsuka Y; Shindoh M
Oncol Rep; 2005 Apr; 13(4):715-20. PubMed ID: 15756447
[TBL] [Abstract][Full Text] [Related]
9. Association of E1AF mRNA expression with tumor progression and matrilysin in human rectal cancer.
Liu HY; Zhou B; Wang L; Li Y; Zhou ZG; Sun XF; Xu B; Zeng YJ; Song JM; Luo HZ; Yang L
Oncology; 2007; 73(5-6):384-8. PubMed ID: 18511876
[TBL] [Abstract][Full Text] [Related]
10. E1AF, an ets-oncogene family transcription factor.
Shindoh M; Higashino F; Kohgo T
Cancer Lett; 2004 Dec; 216(1):1-8. PubMed ID: 15500943
[TBL] [Abstract][Full Text] [Related]
11. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.
Zhong WD; Han ZD; He HC; Bi XC; Dai QS; Zhu G; Ye YK; Liang YX; Qin WJ; Zhang Z; Zeng GH; Chen ZN
Oncology; 2008; 75(3-4):230-6. PubMed ID: 18852494
[TBL] [Abstract][Full Text] [Related]
12. Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Safranek J; Pesta M; Holubec L; Kulda V; Dreslerova J; Vrzalova J; Topolcan O; Pesek M; Finek J; Treska V
Anticancer Res; 2009 Jul; 29(7):2513-7. PubMed ID: 19596921
[TBL] [Abstract][Full Text] [Related]
13. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.
Castellano G; Malaponte G; Mazzarino MC; Figini M; Marchese F; Gangemi P; Travali S; Stivala F; Canevari S; Libra M
Clin Cancer Res; 2008 Nov; 14(22):7470-80. PubMed ID: 19010864
[TBL] [Abstract][Full Text] [Related]
14. E1AF promotes breast cancer cell cycle progression via upregulation of Cyclin D3 transcription.
Jiang J; Wei Y; Liu D; Zhou J; Shen J; Chen X; Zhang S; Kong X; Gu J
Biochem Biophys Res Commun; 2007 Jun; 358(1):53-8. PubMed ID: 17467662
[TBL] [Abstract][Full Text] [Related]
15. Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistry.
Trudel D; Fradet Y; Meyer F; Harel F; Têtu B
Hum Pathol; 2008 May; 39(5):731-9. PubMed ID: 18329693
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer.
Luukkaa H; Klemi P; Hirsimäki P; Vahlberg T; Kivisaari A; Kähäri VM; Grénman R
Acta Otolaryngol; 2008 Apr; 128(4):482-90. PubMed ID: 18368586
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
Dong W; Xiang J; Li C; Cao Z; Huang Z
J Periodontal Res; 2009 Feb; 44(1):125-32. PubMed ID: 19515022
[TBL] [Abstract][Full Text] [Related]
18. E1AF promotes mithramycin A-induced Huh-7 cell apoptosis depending on its DNA-binding domain.
Liu D; Wei Y; Zhou F; Ge Y; Xu J; Chen H; Zhang W; Yun X; Jiang J
Arch Biochem Biophys; 2008 Sep; 477(1):20-6. PubMed ID: 18510939
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients.
Kuivanen T; Jeskanen L; Kyllönen L; Isaka K; Saarialho-Kere U
J Cutan Pathol; 2009 Sep; 36(9):929-36. PubMed ID: 19674198
[TBL] [Abstract][Full Text] [Related]
20. Expression of E1AF, an ets-family transcription factor, is correlated with the invasive phenotype of oral squamous cell carcinoma.
Hida K; Shindoh M; Yoshida K; Kudoh A; Furaoka K; Kohgo T; Fujinaga K; Totsuka Y
Oral Oncol; 1997 Nov; 33(6):426-30. PubMed ID: 9509127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
